CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity. - Liu CC; Yang WB; Chien CH; Wu CL; Chuang JY; Chen PY; Chu JM; Cheng SM; Qiu LY; Chang YC; Hwang DY; Huang CY; et al. (Cell death & disease, 2024)